ArticleOncotarget2016

Transposon-mediated generation of BCR-ABL1-expressing transgenic cell lines for unbiased sensitivity testing of tyrosine kinase inhibitors.

Konstantin Byrgazov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.